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U&rm%ws. The aim of this study was to assess the utility of 
percuteneous h’anWninal coronary rotational ablation in Ihe 
twatment of coronary artery disease. 
Bwkgwmd. Although numerous advances have been made in 
the treatment of corenary artery disezw, rh=ze are 1sion.s with 
complex morphology that mu not amenable lo current k&was- 
celar fhempy. 
Melk& A conseattive series of 242 patients having 302 
c3mmry rdatiooal ailladm prlwdmxs was analyzed. one hml- 
dred ninetctn WW of the patients had prcviou.sly undergone 
pttempted cornnary an&plssty, which was unsucc45sful in 31 
patints (13%). The left ventricular cjeetion frpaioo was normal 
in 1% patients (81%). Tk ablation procedure war attempted ia 
Jo8 VeEspLr and 346 l&Ins. ofihe 315 lesieits treeled, 26 (7.5%) 
were cl&lied lls Am&an Col@e oi Cardi@y~Anmican 
Hcml Aswciarion type A, and 320 (92.5%) as tither type B or 
&De c. 
- - Ralts. Promtornl success WBF achieved in 284 (94%) of the 
302 prondures and 330 (95.4%) of the 346 l&m in which 
Since the introduction of percutaneous rransluminal coro- 
nary angioplasty, the types of lesions considered treatable 
have been expanded by increased operator experience and 
equipment improvement. Coronary atherectomy has rela- 
tively recently been added to the amtamenturium of the 
invasive cardiologist (I). Although directional atherectomy 
has been explored for several years. it has limitations in both 
delivery and effectiveness when the atherectomy device is 
introduced into mtrrow, calcified, tortuous and iung core+ 
nary lesions (2). In contrast, the advent (3-S) of the Heart 
Technology Rotablator has overcome most ofihe aforemen- 
tioned drawbacks of the currently available directional 
atberectomy devices (9-15). Accordingly, this repart details 
the methods. aspects of the learning curve, immediate re- 
suits, comphcations and extended indications developed 
from the experience in the 6rst 302 consecutive procedures 
performed with the Heart Technology Rotablator at our 
Methods 
Patients. Between October 1!3% and May 1992, 242 pa- 
tients underwent 302 discrete percutaneous transluminal 
coronary rotational ablation procedures at our institution. 
Patients were enrolled as part of a multicenter evaluation of 
the Rolabiator for Food and Drug Adminis~tion approval. 
Patients with visible thrombus, unprotected left main coro- 
nary artery or old saphenous vein grafts were excluded. 
Patients who had undergone a prior intervention were not 
excluded unless it had been performed within 1 month before 
rotational ablation and involved a significant dissection. All 
patients signed an informedconsent document that had been 
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approved by the Institutional Review Board of our institu- 
tion. In five patients with a left ventricular ejection fraction 
<30%, assisted (that is. intraaortic balloon pump or cardio- 
pulmonary bypass) rotational ablation was carried out as 
compassionate use after notification of the chair of that 
board. 
Many patients had lesion morphology suitable for balloon 
angioplasty. These patients generally had American College 
of Cardiology/American Heart Association type A and type 
El stenoses (16). As more experience was gained with the 
ablation device, its use was extended to selected type C 
lesions. Compating the last ZOO procedures with the first 100, 
there was a significantly greater use of rotational ablation in 
calcified stenoses (61.5% vs. 31.4%, p i 0.01), eccentric 
lesions (65.1% vs. 44.7%, p < 0.05), lesions >I cm long 
(36.1% vs. 24.5%. p < 0.05) and vessels with diffuse or 
tandem lesions present (30.6% vs. 18.7%. p < 0.05). 
Procedure. The procedure for the use of rotational abla- 
tion consisted of the passage of a flexible 0.009-in. (0.023 cm) 
guide wire with aO.Ol’I-in. (0.043 cm) spring tip through a 9F 
guiding catheter into the coronary artery to be treated by 
rotational ablation. Although the bare wire technique was 
successful in 85% of cases, 15% required the passage of a 
balloon catheter preceded by a O.O14-in. (0.36cm) guide wire 
to exchange for the noncoated Rotablator wire beyond the 
vessel’s narrowest stenosis. In these cases the balloon nose 
was advanced as far as possible into the diseased segment, 
and the 0.014~in. wire was removed. The flexible Heart 
Technology (type C wire or the relatively steerable type A) 
O.OO?Gn. (0.01~in. tip) wire was then passed through the 
balloon nose and positioned as far as feasible beyond the 
stenotic segment. The burr-bearing catheter was then aMe to 
be passed over its uncoated O.CK@-in. wire for definitive 
treatment. The 0.0+&n. wire owes its occasional difficulties 
to its high coefficient of friction, a feature related to the 
absence of Teflon or other lubricious coating common to 
standard angioplasty guide wires. 
After ihe O.GOP-in. wire was positioned distally in the 
appropriate vessel, the diamond-coated burr was advanced 
through the 9F guiding catheter and carefully set just prox- 
imal to the ingress of the lesion. Extreme care to maintain 
the coaxial position of the burr with respect to the guiding 
catheter was required to prevent the stalling of the air 
turbine when entering vessels that bent away fmm the 
guiding catheter at a sharp angle. 
Once the position of the burr and the burr/artery ratio 
were fluoroscopically verified, the device was actuated by a 
foot switch, and the spinning burr advanced slowly into the 
lesion at a starting in vitro speed of 190,OlM to ~OO,CIOO rpm. 
The general approach was to not allow a decrease >lO% in 
rotationa: speed of the burr when it cam‘. into contact with 
the stenotic surface. A continuous saline infusion was used 
tc> lubricate the drive shaft. This infusate was maintained at 
300 mm Hg during the entire course of the use of each 
device. 
In the 346 lesions in which ablation was attempted, an 
average of 2 i 1 burrsilesion was used. A mean of d ? 
2 passes;lesion was required, with the maximal time of 
rotation for each burr of 40 -t 16 s and an average total time 
for all burrs used of 108 2 63 s. The average time for 
rotational ablation proxdures was 47 f 28 min, or approx- 
imate!y 10 min longer than the average balloon angioplasty 
procedure at our institution (37 + 23 min). 
Pacemaker capability was continuously maintained be- 
cause both sinus arrest and a:tioventricular (AV) block, 
although transient, distorted the cardiac rhythm in approri- 
mately 75% of cases. Spasm was treated with nitroglycerin 
or molsidomine (usually by intracoronary administration). 
Significant hypotension occurred in 4.8% of cases but re- 
sponded to fluid and restoration of normal sinus conduction. 
All patients received lO,ooO U of intravenous heparin at the 
beginning of the procedure, and 3,000 U every hour in longer 
procedures. or were treated accordina to the activated 
clotting time determinations made duri& the intervention. 
The activated clotting time was kept at >300 s during the 
procedure. 
Burr sizes were chosen according to the severity of the 
worst stenosis in any given iesion segment, but usually the 
procedure was begun with a 1.25-mm device with sequenc- 
ing of the upsizing to Z.25 mm according to the effects of 
downstream debris (i.e., plaque burden) and vessel size. 
Burr sizes >Z.i5 mm generally require a IOF guiding cathe- 
ter. In our experience, the use of a 9F guiding catheter with 
a 2.25 burr resulted in one case in which the guide was 
damaged (II), although problems have not been encountered 
passing the 2.25-mm burr through the 9F Sherpa guiding 
catheter (Medtronic). 
The early learning curve with this device mandated a 
conservative approach and liberal use of complementary 
balloon angioplasty to achieve safe reduction in percent 
diameter stenosis. As experience was gained, an attempt 
was made to debulk the lesions more aggressively so that a 
higher percent of full lumen diameter was obtained with the 
rotational device alone. BallDon angioplasty in those cases 
(approximately 42% of this series) was performed as a 
touch-up procedure and carried out at a very low pressure 
(0.5 to 2.5 atm), mainly to eliminate spasm or to smooth the 
orthogonally viewed appearance of the vessel, or both. 
The postprocedural care was similar to that utilized for 
balloon angioplasty, although comparison with a concurrent 
series of natients showed that natients underaoine rotational 
ablation were more likely to ak receiving intkve~ous nitro- 
glycerin (80% vs. 64%, p < 0.001) for a longer interval (30 vs. 
24 h. p < 0.05) than were patients undergoing angioplasty. 
Lenglh of hospital stay was not significantly dilTerent be- 
tween the ablation and angioplasty groups (d f 5 vs. 4 + 
3 days). 
Delinitii~s. The following definitions were used. 
Lesion: n ~50% narrowing in vessel lumen diameter on 
m-teriography. 
Primary lesion: one in which no prior ret ascularization 
therapy had been attempted. 
Reslenoric lesion: one in which prior interventional iher- 
spy had been initially successful. 
A~&nc~ive angioplasty: a procedure in which a balloon is 
osed at normal or high pressure after rotational ablation. 
Complemenroiy ongioplostyr a procedure in which a 
balloon is used at very low pressure (0.5 to 2.5 atm) after 
rotationai ablation to relieve vasospasm or to smooth a 
satisfactorily ablated segment. 
M&F cardiac event: occurrence during the initial hospi- 
tal stay of death, a new Q wave myocardial infarction or the 
aced for emergency coronary bypass surgery. 
Non-Q ww myocardial infarcrion: elevation of creatine 
kinase (CK), MB fraction to twice the normal value 
(200 &ml; 6% MB fixaction) with no new electrocardio- 
graphic (ECG) Q waves. 
Q WOW myocordiul infarction: development of new ECG 
Q waves with serum enzymes elevated to twice normal 
levels. 
Technical success~ 8 reduction in the diameter stenosis 
after treatment to a residual stenosis of <SO% and no 
in-hospital occurrence of a major cardiac event caused by 
the treated artery. 
Uasaccessfulluncomplicated: a technically unsuccessful 
ablation attempt that resulted in no major cardiac event. 
Procedural success: technical success achieved in all 
critical &noses with the occurrence of no major cardiac 
events during the hospital stay. 
Lute cardiac event: occurrence of death or myocardial 
infarction after discharge from the initial hospital stay for 
percutaneous transluminal coronary mtatianal ablation. 
Evenr-fie survival: freedom horn late cardiac events. 
Estimated restenosis rate: the number of patients who 
were estimated to have recurrent stettoses based on a 
combination of angiographic results, occurrence of myocar- 
dial infarction or the need for reneat revascularization. 
Statis&! analyses. AU data were entered prospectively 
in the Institute Interventional Cardiology Database. All 
continuous variables are expressed as the mean value r SD. 
Analyses were performed with use of the SPSS statistical 
package. 
Results 
Base& &aracteristLx (Table 1). The 242 Datients were 
predominantly male. Seventy-one percent were in Canadian 
Cardiovascular Society angina class II1 or IV or had unstable 
angina. More than half presented with a history of hypetten- 
sion or hypercholesterolemia. One hundred nineteen (49%) 
had previously mdergonc attempted coronary angioplasty, 
which was unsuccessful in 31 patients (13%). The left 
ventricular ejection fractionwas Xl.45 in 1% patients @I%), 
0.35 toU4in34(14%), 0.25 b0.34in7 (‘L%)and <0.25in 
5 (Z.i%). Of these patients, 133 (55%) had single-vessel 
disease (defined as a vessel with at least one lesion of >5G% 
diameterstenosis), 52 (21.5%) had double-vessel disease, 40 
Prior corom~ bypars sumry 54 22.3 
CCS = Canadian Cardiov~ulaf Society. 
(16.5%) had triole-vessel disease and 17 (7%) had cntadrttnle- 
vessel chsease,.for a total of 425 diseased vessels: 
These 242 patients underwent 302 procedures in which 
rotational ablation was attempted in 308 vessets and ;66 
lesions. Rotational ablation was performed in 92 right coro- 
nary arteries. 158 lef? anterior descending and 58 left circum- 
Rex arteries. Of the 346 lesions treated, 26 (7.5%) were 
classified as American College of CardiotogylAmcdcan 
Heart Association type A. and 320 (92.5%) either type B or 
type C. 
Procedural nutumtc. Procedural sttccess was achieved in 
284 (94%) of the 302 procedures in which rotational ablation 
was used. In five procedures (1.7%). all attempts with a 
Rotablator or balloon were unsuccessful, but no cardiac 
event occurred during the hospital stay. These pnxedures 
involved eccentric and type C lesions. A major cardiac event 
was associated with 13 procedures (4.3%); nine (3%)of these 
complications were due to the ablation procedure. Six 
patients sustained aQ wave myocardial infarctionalone. two 
had a Q wave infarction and required emergency surgery and 
one needed emergency surgery hut did not have a Q wave 
infarction. No procedural deaths were atttibuted to the 
ablation procedure. 
Of the first 302 procedures, 69 (22.8%) were performed as 
a stand-alone procedure. Success was achieved in 95.7% of 
these stand-alone procedures; a major cardiac cYent oc- 
curred in 2.9% of these cases, Sttccess was achieved in 
93.6% of the procedures in which the complementary or 
adjunctive use of a balloon was required; a major cardiac 
event occurred in 4.7% of these cases. 
Lesion outcome. In analyzing !esion outcome immedi- 
ately after use of the abtation procedure before any use of 
adjunct& or complementary balloott therapy, technical 
success was achieved in304 (87.9%) of the 346 stenoses with 
attempted ablation. Of the remaining 42 stenoses, I9 ’ ve 
unsuccessfully treated with ablation. In 1 Iof these 19 cases, 
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Table 2. Results by Lesion and Mcn’phology Subgroups After Rotalional Ablation and Afler All Procedures (Ablation and Balloon 
Dilation) Used 
n Success -Event* Unsuccesrfult Succclr -Event* Uns”ccrssf”n 
All lesions 346 87.9 2.6 9.5 95.4 2.6 2.0 
Tw A 26 100.0 0.0 0.0 96.2 0.0 3P 
Type fb’C 320 86.9 2.8 10.3 95.3 2.8 1.9 
NW 240 85.0 2.9 12.1 94.6 2.9 2.5 
Reltcnotic 106 94.3 1.9 3.8 97.2 1.9 0.9 
Occlusions 23 81.0 0.0 13.0 loo.0 0.0 0.0 
stcnoser 323 87.9 2.8 9.3 95.0 2.8 2.2 
Stcnorir subgroups 
Cl cm 229 89. I 2.2 8.7 95.2 2.2 3.6 
t, cm 94 85.1 4.3 10.6 94.6 4.3 1.1 
Ostial 13 loo.0 0.0 iJ.0 1W.O 0.0 0.0 
Eccrollic 205 86.8 4.4 8.8 93.2 4.4 2.4 
Calcified 107 91.6 1.9 6.5 97.2 I.9 0.9 
‘Definedasmyafatdialinfarclian. emqtnfy rurgeryardeath. tlkfinedas >5d residual diamelrrrlenosis with nomajorcardiac evenl. Dataarepresrnled 
BS number(n) of lesions or as percent of lesions treated with ralalional ablation alone or with ablution and k&on dilation. 
the device crossed the lesion but produced an inadequate 
result; in 6 there was a failure to advance the guide wire and 
in 2 there was a device failure. A successful result was 
achieved with adjunctive balloon therapy in 14 of these 19 
cases. Of the other 23 stenoses, rotational ablation produced 
a flow-limiting dissection in 5, reoeclusion occurred shortly 
after use of the device in I6 and pseudoaneurysmal perfora- 
tions developed in 2 sites. Of those 23 lesions. 17 were 
successfully treated with adjunctive halloon therapy. Snc- 
cess after all intervention (ablation alone or with adjunctive 
or compiementary balloon angioplasty) was achieved in 330 
(95.4%) of the 3461esions in which treatment was attempted. 
Resultsof rotational ablation alone and with adjunctive or 
complementary balloon therapy for various lesion types are 
presented in Table 2. The success rate !#as higher for 
ablation in type A than in type B or C lesions, In ore type A 
lesion, a successful but not optimal result that was followed 
by adjunctive balloon angidasty led to compromised flow 
and an unsuccessful but uncomplicated result. Rotational 
ablatirn was more successful in restenotic than in primary 
lesions, and in lesions 51 cm than in those >l cm long. The 
success rates were extremely high for occlusions and oskial 
stenos:s. 
Fottow-op. Follow-up was obtained 23 months after hos- 
pital discharge or in patients who had returned early for 
evaluation because of a return or worsening of symptoms. Of 
tie 242 patients, 186 were in the group evaluated 23 months 
after hospital discharge. Follow-up was obtained on 182 
of these 186 patients at a mean follow-up interval of 9 -+ 
5 months (Table 3). Of the 182 patients, 169 (92.9%) were 
alive and free of myocardiat infarction. Angiogmphic fol- 
low-up was obtained in 87 patients. Of this sample, 56 
required some reintervention. Although a true restenosis 
rate was not possible to obtain because many asymptomatic 
patients could not be convinced io undergo an&graphic 
follow-up, an attempt was made to calculate an estimated 
restenosis rate by combining angiographic and clinical out- 
come. This analysis yielded an overati estimated restenosis 
rate of 37.4% (68 of 182)). Analysis of selected subgroups 
showed no difference in occurrence of restenosis between 
type A lesions and type B or C lesions (33% vs. 38%) or 
between stand-alone rotational ablation versus ablation with 
adjnnctive complementary balloon therapy (32% vs. 39%). 
In contrast to prior reports, primary lesions had a lower 
restenosis rate than that of restenotic tesions (28% vs. 44%. 
p < 0.01). 0; the 31 patients with prior unsuccessful balloon 
angioplasty, 24 were followed up; of these, 7 (2%) devel- 
oped clinical or argiogmphic evidence of restenosis. 
Coronary angioplasty using present balloon technology is 
still a mainstay of interventional cardiology. Directional, 
laser and rotational atherectomy have not clearly and pre- 
dictably decreased the rate of restenosis. However, the 
impulse to exptore new devices is spurred not only by a 
desire to decrease the rate of restenosis, but by a need to 
treat, through moderately invasive procedures, coronary 
Tahh 3. Follow-Uo Aher Relational Ablation in I82 Patienls 
arteries with more difficult momholoev that would ordinarily . _. 
require coronary bypass surgery. Consequently. narrow, 
calcified and long lesions, so dilfuse as to be inoperable. 
provide the motivation to pursue new approaches. 
&sirmmu@&gv. Although a randomized trial between 
coronary angioplasty and rotational ablation (now in 
progress at this institution) is required to assess the debulk- 
ingeffecl on type A. Band 8, lesions, or indeed any stenosis 
that can be treated with balloon angioplasty, some indica- 
tions of the value of the Rotablator are suggested by this 
study and by comparison with our own balloon angioplasty 
data. In an analysis of l.W lesions treated with balloon 
angioplasty during I998 and 1991 at this institution (18). 
success was not achieved in 8.6% of the 140 calcified lesions 
and in 7.1% of the 14 ostial lesions with attempted dilation. 
Of the 414 lesions >I cm long in which angioplasty was 
attempted, the procedure was unsuccessful in 9.4%. The 
success rates of 95% to lOG% obtained in these subgroups 
with rotational ablation are encouraging although they do not 
differ statistically from those obtained with angioplasty. The 
following are examples of the successful use of rotational 
ablation in several circumstances that are less than optimal 
for conventional balloon angioplasty: 
I. Calcified ostial lesions (see Fig. 1). 
2. Lesions crossable hv wire and balloon that do not 
yield lo high pressures (e.i., 20 atm) (see Fig. 2). 
3. Any lesion in which tortuosity of vessel or profile of 
stenosis is so severe that the 0.014-in. wire crosses, yet no 
balloon will follow (see Fit. 3). 
4. Long, narrow (e.g.: 27 cm) segments of calcified 
diffuse and tubular disease in which balloon angioplasry is 
known to be associated with dissection, inadequate dilatiun 
and higher restenosis rates (see Fig. 4). 
5. Lesions with restenosis after balloon angioplasty. 
which may be less likely to recur again (19) (see Pig. 5). 
One of the most significant findings in our series is the 
effect of debulking on extremely calcified lesions. For exam- 
Figure t. 8, Right coronary artsy wi!b a Ime cakiikd 0stiaJ &ion 
(mow). b, The same vessel I year law after satnd-alone rotalional 
ablarion of the ortial lesion. 
pie. in the class of lesion depicted in Figre 2, a calcified ring 
prevents dilation of a lesion with a conventional balloon 
(even at pressures in excess of 20 atm). However, rhe prior 
dsoulking of such a stenosis with rotational ablation even 
with a relatively small tl.5 mm) burr. may render a vessel 
treatable with a 3.5mm balloon i&ted to only 6 atm of 
pressure. This observation suggests that an inner core OF 
napkin ring calcification prevents even the highest pressure 
balloons from affecting certain old lesions. This remarkable 
change in the pressure response of the lesion after the 
debulking oi only I.5 mm of the vessel is a striking and 
consistent phenomeoon. 
Complementary and adjuuetive b&boa use. Buchbinder 
et al. (19) have termed normal and high pressure balloon 
angioplasty after rotational ablation “adjunctive.” Tlx use 
of an adjunctive balloon means that a true attempt to carry 
out balloon angioplasty was m&z either because abrupt 
closure (i.e.. no reflow phenomenon) could not be reversed 
with the burr alone or because a significant dissection 
resulted in the lesion. In these cases, the b&on is used to 
salvage the rotational ablation. Salvage balloon angioplasty 
after rotational ablation in our series occurredin 23 (6.7%) of 
the lesions with attempted ablation. 
The importance of complementary baIIoon angioplasty is 
unclear at this time. It is possible that 60% to 80% of all 
patients undergoing rotational ablation could be treated with 
ablation alone. This approach might be utilized in most cases 
if the operator deals solely with type A and type B, lesions. 
However, the useof the device in type A and type B, lesions 
is argua.ble because those vessels generally respond quite 
well to balloon angioplasty. The utility of rotational ablation 
in type A and type B, lesions has to be based either an the 
Figttre 2. a, Lateral view of the left caronsry artery. The arrow 
points to the site of occlusion of the left anterior descendig vcsscl. 
The patent vessel under the arrow is the diagonal branch. b, Wire 
and angioplssty b&en in the left anterior descending artery. The 
arrow pohftr to persistent indentation et a balloon pressure of 
22 atm. c, Same artery after angioplasty with the area of the lesion 
that failed to yield to ballcan pressure at 22 atm. d, Same artery 
cleared of the calcified totally occluded segment r&r rotational 
ablation; that is. the napkin ring calcification seen in b has txea 
eliminated by the ablation pmwdurc. 
achievement of a lower restenosis rate or on a lower inci- 
dence of immediate complications. In the absence of tortu- 
osity or calcification, there is no obvious clinical difference 
in &come of therapy of type A and 8, lesions between 
balloon attgioplasty and rotational ablation. As lesions be- 
come more tot~~ts, elongated and calcified, the incidence 
of balloon-relattti dissection (Fig. 4) may increase. The 
primary treatment of tortuous, calcified, lengthy lesions has 
an extremely low incidence of dissection after the use of 
rotational ablation alone. However, the general question of 
whether the restenosis rate will be diminished as a result of 
a cosmetic touch up at low pressure of an otherwise satis- 
factory stand-alone case, cannot yet be answered with 
certainty. 
Camplieatkxis. The complication rate in terms of Q wave 
myocardial infarction, acute phase reactants or emergency 
bypass surgery was extremely low and quite comparable to 
that dour general angioplasty series. Indeed, no emergency 
surgery was required in the entire series unhl20!3 procedures 
had been performed. Complications, including Q wave in- 
farction, were not related to the complexity of the lesions 
treated. The formation d microsmboli did not appear to be 
a pmblem in this series. Serial measurements of CK-MB 
elevation during the 24 h after rotational ablation were 
performed on a submoup of 149 patients and demonstrated 
only mildly significant increases in 1 I% of patients with no 
corresponding ECG changes, a finding similar to that in our 
angioplasty series. 
After 200 procedures, an attempt to use rotational t&la- 
tion alone to increase the burr/artery ratio to >%t% of the 
full lumen diameter of the vessel resulted in several in- 
stances of complication that led to pseudoaneurysm forma- 
tion. The consequences of these aneurysms wore benign. 
Small psettdoaaeurysms were treated by balloon angioplasty 
either with a Stack balloon, or by prolonged inflation with a 
normal balloon, such that the neck of the aneurysm was 
blocked by the balloon and Bow was reestablished in the 
vessel without extravasation. In one ease, a large pseudo 
aneurysm occurred that responded immediately to a rela- 
tively long Stack balloon inflation. It was restudied at 1 
month, after which no extravasation of contrast medium or 
psettdoaneutysm could be identified. 
The assessment of complications in rotational ablation is 
summarized by a twofold observation: 
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1. The sequentiai utilization of small to large burrs Figure 3. a. Left circumflex coronary artery with revere subtotal 
without “skipping” to the final burr sire too early in the stenorls(arrowl. b,Althcqh a0.014-in.l0.036cm)wire hascrossed 
procedure decreases the plaque burden and lowers the risk the tesion. no balloon (Axed or over the wire1 could woss the severe 
of dissection, macnxmbolus or severe vasospasm. This obser- narrowing (arrow). Note that the balloon center Mat) aligns with the 
vation is suppxted by an analysis of the 23 lesions in which 
sternal wire (compare withal. e, Rotablator wire is visible disraRy in 
there was either severe dissection. occlusion or perfor&ion 
the mtery. The lesion (arrow) has already been successfully dc- 
bulked by the mtating diamond bun. Significant vawspa~m is 
tier the ablation procedure; in II (63.8%) of these cases. burr preset in the entire lefi circumflex system. d. Final rotational 
sizes were skipped and in 6(26.1%) a relatively targc burr(l.75 ablation result after ballowl treatment for left circumtkr artery 
SPPSrn. 
Figure 4. A, Right coronary’ artery in the right 
anterior oblique view showing adiffuse, calcified 
lengthy atherosclerotic segment. B, Final result 
after multiple burr ablations from I.25 up to 
2.15 mm. The singkihir. arrow shows the ectatic 
reference point present in A, that is. before 
treatment. 
Figwe 5. 8, Left coronary artery in lateral view. The arrow shows 
a segment with restenosis after balloon angioplasty. b, Arvmv shows 
the same area after smooth clearance of fibrosis by stind.alone 
rotational atherectomy. 
to 2.00) was used as the lint device. These untoward occur- 
rences were found in ~20% of the other cases. 
2. Overestimation of the final burr size (for example, an 
attempt to reach a butrlartety ratio of 0.9 or 1.0) may debulk 
a vessel completely but may alsu lead to a higher incidence 
of pseudoaneurysm. Consequently, we have adopted the 
policy of choosing initial burr sizes in inverse propartion to 
the severity of stenosis in the vessel. Thus, the more severe 
the stenosis, the smaller is the initial burr size chosen to 
recanalize the lesion. Stepwise utilization of larger sizes, up 
to burr/artery ratios of ~0.75, seem to offer the optimal 
debullcing formula with the lowest complication rate. Very 
little adjunctive, complementary or salvage angioplasty is 
necessary if these guidelines are followed. 
Rertcnosls. Although the high success rates of rotational 
ablation appear similar to those of balloon angioplasty, the 
cases now subjected to ablation involve increasingly more 
complex lesion morphology that is often unsuitable for 
angioplasty. In the present series, 49.1% of the patients had 
prior coronary angioplasty, and 13% had documentation of 
failed balloon angioptasty. Consequently, although the re- 
stenosis rate with rotational ablation (37.4%. overall) may 
not be significantly lower than that of reported balloon 
angioplasty data (21) and other new devices (22.23). it must 
be considered in light of the fact that many of the cases 
treated were, by lesion length and diffuse morphology alone, 
unsuitable for balloon angioplasty and, hence, would have 
been referred for elective bypass surgery. The importance of 
this observation is underscored by the fact that of the 31 
patients with unsuccessful prior balloon angioplasty, 17 of 
the 24 with follow-up have not required any reintervention 
and have avoided surgery. 
Lllitatlons of the study. One of the limitations of thr 
present study is the absence of randomization. A random- 
ized study is in progress for type A, B and 8, lesions, but 
because an increasing number of patients referred to our 
center have already had unsuccessful balloon angloplasty, 
many must be excluded from the randomized trial. 
The other major llltation of this study is the lack of 
angiogruphic foilow-up on patients. Although prevlons data 
suggest (20) that the rate of restenosis is -22% to 25% in 
patients undergoing rotational ablation after balloon an&- 
plasty restenosis, complete an&graphic follow-up of all 
patients has not yet yielded a definitive restenosis rate. In 
the present series, the follow-up of IS2 patients has yielded 
an overall Qmonth restenosls rate of -37%. Only 87 (48%) 
of 182 patients in the series have been restudied after 6 
months, and clinically well patients are generally reluctant to 
undergo further angiography. Thus, the reluctance of some 
clinically well patients to undergo further invasive tasting 
has delayed a more detailed assessment of restenosis and 
may skew the restenosis data unfavorably until more at&lo- 
graphic restudies are obtained. 
Conclusioas. The results of the lirst 302 rotational abla- 
tion procedures performed in our institution demon&are the 
high degree of success and effectiveness of the device, even 
in complex type C lesions tbat previously would have been 
referred for elective bypass surgery. The complications 
experienced are not significantly different from those of 
conventional balloon angioplasty, provided that plaque bur- 
den is slowly generated. Consequently, tbe availabllky of 
rotational ablation doubtless will extend the spectrum of 
treatable coronary atherosclerotic disease. 
We thank Kim Gonulw far typing lhis marmxtipt and lohn Volkerl fw 
prepark@ lhr SSUSS. 
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